-
Why The Best Outcome For Intel Shareholders Is To Break Up The Chipmaker
Monday, November 2, 2020 - 11:50am | 430Intel Corporation (NASDAQ: INTC), though retaining the pole position in many of the segments it operates in, has lost the aura of invincibility around it. An analyst at Northland Capital Markets is of the view the company is better off splitting its business units. The Intel Analyst: Gus Richard...
-
Analyst Warns Of AMD Shares 'Melting Up' By Year's End, Says Stock Is 'Running Ahead Of Fundamentals'
Thursday, November 21, 2019 - 11:20am | 380Advanced Micro Devices, Inc. (NASDAQ: AMD) shares have been on a tear, thanks to its strong product momentum. An analyst at Northland Capital Markets, however, thinks shares are ahead of the fundamentals. The Analyst Gus Richard downgraded AMD from Outperform to Market Perform and maintained his $...
-
Northland Lifts New Age Beverages Price Target After Morinda Purchase, Eyes Nationwide CBD Opportunity
Monday, January 7, 2019 - 2:22pm | 460New Age Beverages Corporation (NASDAQ: NBEV) shares were trading slightly higher Monday after an analyst report from Northland Capital Markets focused on the company's latest acquisition and the passage of the federal Farm Bill. The Analyst Analyst Mike Grondahl reiterated an...
-
Northland Downgrades AMD On 'Irrational Expectations'
Thursday, September 27, 2018 - 9:48am | 420Advanced Micro Devices, Inc. (NASDAQ: AMD) has been one of the biggest market winners of 2018, but one Wall Street analyst said Thursday that the AMD rally has finally run its course. The Analyst Northland Capital Markets analyst Gus Richard downgraded AMD from Outperform to Market...
-
Northland Downgrades Tilray After Huge Run
Thursday, September 6, 2018 - 9:13am | 423On Thursday, yet another analyst joined the growing chorus saying marijuana stock valuations are getting overheated. The Analyst Northland Capital Markets analyst Mike Grondahl downgraded Tilray Inc (NASDAQ: TLRY) from Outperform to Market Perform and removed its $60 price target. The Thesis...
-
Analyst: ZTE Ban Could Spark Consolidation In Optical Space
Wednesday, April 18, 2018 - 8:27am | 445The U.S. government banned U.S.-based telecom companies from selling hardware and software components to the Chinese company ZTE for seven years. The announcement had a ripple effect across the entire optics sector and could even trigger industrywide consolidation, according to Northland Capital...
-
5 Reasons Finisar Is An Analyst's Top Pick For 2018
Friday, December 29, 2017 - 1:18pm | 3812017 was a challenging year for Finisar Corporation (NASDAQ: FNSR), with the stock losing more than 30 percent. But some on Wall Street are optimistic the coming year will be a profitable one for shareholders of the optical communications company. The Analyst Northland Capital Markets'...
-
With Lumentum Down 20% Over 2 Weeks, This Analyst Just Upgraded The Stock
Monday, December 11, 2017 - 1:47pm | 406Lumentum Holdings Inc (NASDAQ: LITE), a supplier of optical components for the telecom transport and switching markets, has seen its stock fall 20 percent over the past two weeks and some on Wall Street are now encouraging investors to buy the dip. The Analyst Northland Capital Markets' Tim...
-
Advanced Micro Devices Has A Slate Of Exciting Products Coming In 2017
Friday, October 21, 2016 - 10:19am | 377Advanced Micro Devices, Inc. (NASDAQ: AMD) reported better-than-anticipated Q3:16 results, driven by the strength of its gaming business, as well as the recent success of Polaris in the GPU market. Northland Capital’s Tom Sepenzis reiterated an Outperform rating on the company, with a price...
-
LendingTree Clients Apparently Very Happy; Northland Analyst Hikes Target After Latest Conversation
Monday, April 4, 2016 - 9:31am | 282Comments from a mid-tier mortgage lender, which uses Lendingtree Inc (NASDAQ: TREE) for mortgage leads, support the latter’s strong position in the mortgage lending market. Northland Capital Markets’ Mike Grondahl maintained an Outperform rating for the company, while raising the...
-
What Does Jazz Pharma's Latest FDA Approval Mean?
Thursday, March 31, 2016 - 9:32am | 218The US FDA granted marketing approval for Defitelio® [defibrotide sodium] for the treatment of adult and pediatric patients with hepatic VOD, also known as sinusoidal obstruction syndrome [SOS], with renal or pulmonary dysfunction following HSCT. Jazz Pharmaceuticals plc - Ordinary Shares (...
-
Allegations Mallinckrodt Is Hiking Acthar Prices Called 'False'
Wednesday, March 16, 2016 - 2:55pm | 302In a new report, Northland Capital Markets analyst David Buck reiterates the firm’s bullish take on Mallinckrodt PLC (NYSE: MNK), despite unfavorable comparisons to the crashing Valeant Pharmaceuticals Intl Inc (NYSE: VRX) in recent days. The CNBC appearance by CEO Mark Trudeau on Tuesday...
-
Supernus Pharma Should Have More Strength After Epilepsy Drug Patent Decision, Northland's Buck Says
Thursday, March 10, 2016 - 11:23am | 382Supernus Pharmaceuticals Inc (NASDAQ: SUPN) is up more than 3 percent Thursday and more than 17 percent year-to-date. According to a press release, Supernus' most recent earnings release earlier in March came in as records for both the fourth quarter and the full year 2015. "2015 was...
-
Five9 Shares Climb After Q4 Results, Outlook Top Street View
Wednesday, February 24, 2016 - 3:26pm | 514Shares of Five9 Inc (NASDAQ: FIVN) surged 10 percent after the provider of cloud software for contact centers reported better-than-expected results for the fourth quarter. The company's revenue outlook for the first quarter and full year also topped Street view. The company reported a loss...
-
Twitter's Crash Is Weighing On GSV Capital
Tuesday, February 16, 2016 - 11:31am | 289In a new report, Northland Capital Markets analyst Jeff Houston reduced the firm's price target for GSV Capital Corp (NASDAQ: GSVC), but reiterated the firm's bullish outlook for the stock. Houston also provides updates on some of GSV's best and worst-performing holdings. One of GSV...